Skip to content

application of bone allograft in mastoidectomy

Evaluation of application of CenoBone (Bone Allograft) in canal wall down mastoidectomy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131020015083N4
Enrollment
30
Registered
2022-03-14
Start date
2022-03-16
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholesteatoma of mastoid. Cholesteatoma of mastoid

Interventions

Intervention group: CWD mastoidectomy with mastoid obliteration.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: mastoidectomy due to chronic otitis media with cholesteatoma

Exclusion criteria

Exclusion criteria: history of systemic disease mastoidectomy due to tumors

Design outcomes

Primary

MeasureTime frame
Graft success rate. Timepoint: postoperative week ?, second month, third month, fourth month, sixth month. Method of measurement: microscopic otoscopy.;Timing of epithelialization. Timepoint: Postoperative week ?, second month, third month, fourth month, sixth month. Method of measurement: Microscopic otoscopy.;Presence of granulation tissue. Timepoint: Postoperative week ?, second month, third month, fourth month, sixth month. Method of measurement: Microscopic otoscopy.;Otorrhea. Timepoint: Postoperative week ?, second month, third month, fourth month, sixth month. Method of measurement: Microscopic otoscopy.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Faramarzi

Shiraz University of Medical Sciences

mfaramarzi11@gmail.com+98 71 3629 1470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026